vaccine, influenza




Zuellig Pharma
Concise Prescribing Info
Influenza virus surface antigens (haemagglutinin & neuraminidase)
Prophylaxis of influenza, especially for those w/ increased risk of associated complications in adults & childn from 6 mth of age. Recommended for the following patients: ≥65 yr; adult & childn w/ chronic disorders of the pulmonary or CV systems (including asthma), chronic metabolic disease (eg, DM), chronic renal dysfunction & immunodeficiencies due to disease or immunosuppressants (eg, cytostatics or corticosteroids) or radiotherapy; childn & teenager (6 mth-18 yr) who receive long-term acetylsalicylic acid containing medication, who might be at risk for developing Reye's syndrome following an influenza.
Dosage/Direction for Use
Adult & childn ≥36 mth 0.5 mL by IM or deep SC inj. Childn 6-35 mth 0.25 or 0.5 mL by IM or deep SC inj. Childn who have not previously been vaccinated should receive a 2nd dose after an interval of at least 4 wk.
Hypersensitivity to influenza virus surface antigen, traces of eggs (eg, ovalbumin, chicken proteins), formaldehyde, cetyltrimethylammonium Br, polysorbate 80 or gentamicin. Postpone immunisation in patients w/ febrile illness or acute infection.
Special Precautions
Do not administer intravascularly. Individuals w/ thrombocytopenia or any coagulation disorder. Anxiety-related reactions [including, vasovagal (syncope), hyperventilation or stress-related reactions] can occur following, or even before any vaccination & can be accompanied by several neurological signs (eg, transient visual disturbance, paraesthesia & tonic-clonic limb movements during recovery). Have procedures in place to avoid injury from faints. Not effective against all possible strains of influenza virus. Patients w/ endogenous or iatrogenic immunosuppression may have insufficient Ab response. Interference w/ serological testing. Contains 23 mg of Na and 39 mg of K. Childn <6 mth.
Adverse Reactions
Headache; sweating; myalgia, arthralgia; fever, malaise, shivering, fatigue, local reactions (eg, redness, swelling, pain, ecchymosis, induration).
Drug Interactions
May diminish immunological response w/ immunosuppressants. False positive results in serology tests using ELISA for HIV1, hepatitis C & HTLV1.
ATC Classification
J07BB02 - influenza, inactivated, split virus or surface antigen ; Belongs to the class of influenza viral vaccines.
Influvac vaccine inj 0.5 mL
0.5 mL x 1's
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.
Sign up for free
Already a member? Sign in